Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vericiguat in Mild to Moderate Calcific Aortic Valve Stenosis
ChiCTR2500108507Phase 2Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in calcific aortic stenosis (AS) comparing Vericiguat intervention group with Placebo control group (2 arms). Primary endpoint: Aortic valve calcification score at 24 months. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
vericiguat
03
Conditions
calcific aortic stenosis (AS)
Beyond the preview
Go deeper on ChiCTR2500108507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500108507.